KEGG MEDICUS Search Result |
Top |
| Entry | Name | Name(TN) | Disease |
|---|---|---|---|
| D11027 |
Ropeginterferon alfa-2b (INN) Ropeginterferon alfa-2b (genetical recombination) (JAN) Ropeginterferon alfa-2b-njft |
Besremi (TN) | Polycythemia vera [DS:H00012] |
| D11028 |
Cenegermin (INN) Cenegermin-bkbj |
Oxervate (TN) | |
| D11029 |
Andexanet alfa (USAN/INN) Andexanet alfa (genetical recombination) (JAN) |
Andexxa (TN) Ondexxya (TN) |
|
| D11030 | Netarsudil (USAN/INN) | ||
| D11031 |
Netarsudil mesylate (USAN) Netarsudil mesilate (JAN) |
Rhopressa (TN) | Open-angle glaucoma [DS:H00612] |
| D11032 | Plitidepsin (INN) | ||
| D11033 |
Lutetium (177Lu) oxodotreotide (INN) Lutetium (177Lu) dotatate |
Lutathera (TN) | Gastroenteropancreatic neuroendocrine tumors (somatostatin receptor-positive) [DS:H00045] |
| D11034 |
Insulin glargine and lixisenatide Insulin glargine (genetical recombination) and lixisenatide |
Soliqua (TN) | Type 2 diabetes mellitus [DS:H00409] |
| D11035 | Fluticasone furoate, umeclidinium bromide and vilanterol | Trelegy ellipta (TN) | Chronic obstructive pulmonary disease [DS:H01714] |
| D11036 | Glycopyrrolate and formoterol | Bevespi (TN) | Chronic obstructive pulmonary disease [DS:H01714] |
| D11037 | Patiromer sorbitex calcium (JAN/USAN) | Veltassa (TN) | |
| D11038 | Ulixertinib (INN) | ||
| D11039 | Bictegravir, emtricitabine and tenofovir alafenamide | Biktarvy (TN) | HIV-1 infection [DS:H01563] |
| D11040 | Apalutamide (JAN/INN) | Erleada (TN) | Prostate cancer [DS:H00024] |
| D11041 | Tezacaftor (USAN/INN) | ||
| D11042 | Tezacaftor and ivacaftor | Symdeko (TN) |
Cystic fibrosis (CFTR F508del homozygous mutation) [DS:H00218] Cystic fibrosis (at least one mutation in CFTR) [DS:H00218] |
| D11043 |
Ertugliflozin pidolate Ertugliflozin L-pyroglutamic acid |
Steglatro (TN) | Type 2 diabetes mellitus [DS:H00409] |
| D11044 | Enasidenib mesylate (USAN) | Idhifa (TN) | Acute myeloid leukemia (IDH2 mutation positive) [DS:H00003] |
| D11045 | Darolutamide (JAN/USAN/INN) | Nebeqa (TN) | Prostate cancer [DS:H00024] |
| D11046 | Delgocitinib (JAN/USAN/INN) | Corectim (TN) | |
| D11047 |
Domagrozumab (USAN/INN) Domagrozumab (genetical recombination) (JAN) |
||
| D11048 |
Upadacitinib hydrate (JAN) Upadacitinib hemihydrate |
Rinvoq (TN) |
Rheumatoid arthritis [DS:H00630] Psoriatic arthritis [DS:H01507] Atopic dermatitis [DS:H01358] Ulcerative colitis [DS:H01466] Ankylosing spondylitis [DS:H01674] |
| D11049 | Epacadostat (JAN/USAN/INN) | ||
| D11050 |
Isatuximab (USAN/INN) Isatuximab (genetical recombination) (JAN) Isatuximab-irfc |
Sarclisa (TN) | Multiple myeloma [DS:H00010] |
| D11051 | Vericiguat (JAN/USAN/INN) | Verquvo (TN) | |
| D11052 |
Risankizumab (USAN/INN) Risankizumab (genetical recombination) (JAN) Risankizumab-rzaa |
Skyrizi (TN) |
Plaque psoriasis [DS:H01656] Psoriatic arthritis [DS:H01507] Crohn's disease [DS:H00286] Ulcerative colitis [DS:H01466] |
| D11053 | Encorafenib (JAN/USAN/INN) | Braftovi (TN) |
Melanoma (BRAF mutation positive) [DS:H00038] Colorectal cancer (BRAF mutation positive) [DS:H00020] |
| D11054 |
Ravulizumab (USAN/INN) Ravulizumab (genetical recombination) (JAN) |
Ultomiris (TN) |
Paroxysmal nocturnal hemoglobinuria [DS:H01053] Atypical hemolytic uremic syndrome [DS:H01434] |
| D11055 |
Fremanezumab (USAN/INN) Fremanezumab (genetical recombination) (JAN) Fremanezumab-vfrm |
Ajovy (TN) | |
| D11056 | Mirtazapine hydrate (JAN) | ||
| D11057 |
Adegrapepimut-S (USAN) Adegramotide (INN) |
||
| D11058 | Adegramotide acetate (JAN) | ||
| D11059 |
Elatipepimut-S (USAN) Nelatimotide (INN) |
||
| D11060 | Nelatimotide trifluoroacetate (JAN) | ||
| D11061 | Osilodrostat (USAN/INN) | ||
| D11062 | Osilodrostat phosphate (JAN/USAN) | Isturisa (TN) | Cushing's disease [DS:H01431] |
| D11063 | Evocalcet (JAN/INN) | Orkedia (TN) | |
| D11064 | Sitagliptin and ipragliflozin | Sujanu (TN) | |
| D11065 | Fosnetupitant (USAN/INN) | ||
| D11066 | Ertugliflozin and sitagliptin | Steglujan (TN) | Type 2 diabetes mellitus [DS:H00409] |
| [ KEGG | NETWORK | DISEASE | DRUG | MEDICUS ] |